Phacoanaphylactic uveitis
Learn about Phacoanaphylactic uveitis, its reported features, relevant specialists, and questions to discuss at a medical consultation.
Also known as: Endophthalmitis phacoanaphylactica; Lens-induced endophthalmitis; Lens-induced iridocyclitis; Lens-induced uveitis; Phacoallergic endophthalmitis; Phacoantigenic endophthalmitis and 1 more
Phako-anaphylactic endophthalmitis
The sources compiled here do not cover: diagnosis, treatment, prevention, prognosis, prevalence. Ask the treating doctor about these.
What it is
From: Orphanet
A rare ophthalmic disorder characterized by a zonal granulomatous inflammatory reaction centered around the lens secondary to its traumatic rupture. Signs and symptoms include photophobia, ocular irritation or pain, blurred vision, redness, mutton-fat keratic precipitates, posterior synechiae, and sometimes hypopyon. Intraocular pressure may be elevated due to blockage of the trabecular meshwork by inflammatory cells or lens material.
Reported clinical features and what the terms mean
The following findings are associated with this condition in Orphanet. They are not a checklist for diagnosing yourself, and they do not all occur in every affected person. Some are examination, imaging or laboratory findings that cannot be recognised at home.
The frequency labels describe how often a finding was reported among people with the condition in the source. They do not give the chance that a person with that symptom has the condition. Definitions below reproduce HPO terminology; they explain the term, not the likely severity in an individual.
- Ocular pain · Very frequent (99-80%)
- An unpleasant sensation characterized by physical discomfort (such as pricking, throbbing, or aching) localized to the eye.
- Pseudophakia · Very frequent (99-80%)
- The term pseudophakia refers to having an artificial lens implanted after the natural eye lens has been removed. During cataract surgery the natural cloudy lens is replaced by an pseudophakia intraocular lens (IOL).
- Visual loss · Very frequent (99-80%)
- Loss of visual acuity (implying that vision was better at a certain time point in life). Otherwise the term reduced visual acuity should be used (or a subclass of that).
- Abnormal corneal endothelium morphology · Frequent (79-30%)
- Abnormality of the corneal endothelium, that is, the single layer of cells on the inner surface of the cornea.
- Abnormal pupil morphology · Frequent (79-30%)
- An abnormality of the pupil.
- Anterior uveitis · Frequent (79-30%)
- Inflammation of the uveal tract in which the primary site of inflammation is the anterior chamber.
- Blurred vision · Frequent (79-30%)
- Lack of sharpness of vision resulting in the inability to see fine detail.
- Conjunctival hyperemia · Frequent (79-30%)
- Dilatation of the blood vessels of the conjunctiva leading to a red appearance of the sclera.
- Keratitis · Frequent (79-30%)
- Inflammation of the cornea.
- Photophobia · Frequent (79-30%)
- Excessive sensitivity to light with the sensation of discomfort or pain in the eyes due to exposure to bright light.
- Posterior uveitis · Frequent (79-30%)
- Inflammation of the uveal tract in which the primary site of inflammation is the retina or choroid.
- Red eye · Frequent (79-30%)
- A reddish appearance over the white part (sclera) of the eye ranging from a few enlarged blood vessels appearing as wiggly lines over the sclera to a bright red color completely covering to sclera.
- Vitreoretinopathy · Frequent (79-30%)
- Ocular abnormality characterized by premature degeneration of the vitreous and the retina that may be associated with increased risk of retinal detachment.
- Abnormal vitreous humor morphology · Occasional (29-5%)
- Any structural anomaly of the vitreous body.
Other findings in the same source
From: Orphanet
Additional reported features include Anterior chamber cells grade 1+ (Occasional (29-5%)); Anterior chamber flare grade 1+ (Occasional (29-5%)); Corneal keratic precipitates (Occasional (29-5%)); Corneal stromal edema (Occasional (29-5%)); Cystoid macular edema (Occasional (29-5%)); Hyphema (Occasional (29-5%)); Hypopyon (Occasional (29-5%)); Macular edema (Occasional (29-5%)); Ocular hypertension (Occasional (29-5%)); Panuveitis (Occasional (29-5%)). This is a selected summary, not a complete description of the condition.
When it may begin
From: Orphanet
Adult
Inheritance in the source
From: Orphanet
Not applicable
Which doctor should you see?
The suggested department for discussing Phacoanaphylactic uveitis is Ophthalmology, with a ophthalmologist as the relevant type of clinician. Ophthalmologist; paediatric services for children as appropriate.
This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.
How to prepare for an assessment
Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.
Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.
- Which part of the eye or visual pathway is affected?
- What change in vision requires immediate contact with the eye service?
- What are the aims and alternatives of any proposed eye treatment?
Treatment discussions and follow-up
The material gathered for this draft does not provide a complete condition-specific treatment pathway for Phacoanaphylactic uveitis. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.
Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.
The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.
When to seek emergency help
Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.
This condition is usually assessed by an ophthalmologist. Every profile shows the doctor’s registration and what has been checked.
All ophthalmology conditions →
Sources
- Orphanet — Phacoanaphylactic uveitis — Orphadata Science, CC BY 4.0
- Human Phenotype Ontology Consortium — terminology definitions — HPO licence; definitions reproduced without alteration
- Government of India — Emergency Response Support System — Official reference for India emergency number
Source: MedlinePlus, National Library of Medicine. Orphadata Science: Free access data from Orphanet. © INSERM 1999; July 2026 data, CC BY 4.0. This product uses the Human Phenotype Ontology (hp/releases/2026-09-01). Only sources listed for this article apply. Source material has been selected and arranged; HPO definitions are reproduced without alteration. No source organisation endorses this compilation. Köhler S et al. The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Research 2014;42(D1):D966–D974. doi:10.1093/nar/gkt1026.
General information, not advice about your situation. Errors can be reported through the corrections process. Reference TDI-C-1844.